IL140039A0 - Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres - Google Patents

Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres

Info

Publication number
IL140039A0
IL140039A0 IL14003998A IL14003998A IL140039A0 IL 140039 A0 IL140039 A0 IL 140039A0 IL 14003998 A IL14003998 A IL 14003998A IL 14003998 A IL14003998 A IL 14003998A IL 140039 A0 IL140039 A0 IL 140039A0
Authority
IL
Israel
Prior art keywords
ureas
carbamates
carboxylic acid
acid isosteres
heterocyclic
Prior art date
Application number
IL14003998A
Other languages
English (en)
Original Assignee
Guilford Pharm Inc
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc, Amgen Inc filed Critical Guilford Pharm Inc
Publication of IL140039A0 publication Critical patent/IL140039A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL14003998A 1998-06-03 1998-12-03 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres IL140039A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8784498P 1998-06-03 1998-06-03
PCT/US1998/025570 WO1999062879A1 (en) 1998-06-03 1998-12-03 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres

Publications (1)

Publication Number Publication Date
IL140039A0 true IL140039A0 (en) 2002-02-10

Family

ID=22207585

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14003998A IL140039A0 (en) 1998-06-03 1998-12-03 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres

Country Status (17)

Country Link
US (2) US20020007075A1 (xx)
EP (1) EP1082301A1 (xx)
JP (1) JP2002516903A (xx)
KR (1) KR20010052502A (xx)
CN (1) CN1299346A (xx)
AU (1) AU1620499A (xx)
BG (1) BG105014A (xx)
BR (1) BR9815881A (xx)
CA (1) CA2333960A1 (xx)
EA (1) EA200001246A1 (xx)
HU (1) HUP0102847A2 (xx)
IL (1) IL140039A0 (xx)
NO (1) NO20006111L (xx)
PL (1) PL348671A1 (xx)
SK (1) SK18292000A3 (xx)
WO (1) WO1999062879A1 (xx)
ZA (1) ZA9811061B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302757A (ja) * 1999-04-16 2000-10-31 Shiseido Co Ltd Ｎ−置換ピペリジン誘導体
CN1382140A (zh) 1999-07-09 2002-11-27 奥索-麦克尼尔药品公司 具有神经营养活性的吡咯烷和哌啶、以及含有它们的相关组合物
EE200300168A (et) 2000-10-30 2003-06-16 Janssen Pharmaceutica N.V. Tripeptidüülpeptidaasi inhibiitorid, nende valmistamine ja kasutamine ravimina ning neid sisaldav farmatseutiline kompositsioon
ES2647664T3 (es) 2011-01-04 2017-12-26 Novartis Ag Compuestos de indol o análogos de los mismos útiles para el tratamiento de la degeneración macular relacionada con la edad (AMD)
JP6209605B2 (ja) 2012-06-28 2017-10-04 ノバルティス アーゲー ピロリジン誘導体、および補体経路調節因子としてのその使用
ES2712190T3 (es) 2012-06-28 2019-05-09 Novartis Ag Moduladores de la vía del complemento y sus usos
US9468661B2 (en) 2012-06-28 2016-10-18 Novartis Ag Pyrrolidine derivatives and their use as complement pathway modulators
JP6273274B2 (ja) 2012-06-28 2018-01-31 ノバルティス アーゲー 補体経路モジュレーターおよびその使用
JP6154897B2 (ja) 2012-06-28 2017-06-28 ノバルティス アーゲー ピロリジン誘導体、および補体経路調節因子としてのその使用
KR20150036481A (ko) 2012-07-12 2015-04-07 노파르티스 아게 보체 경로 조절제 및 그의 용도
WO2023090853A1 (ko) * 2021-11-19 2023-05-25 고려대학교 세종산학협력단 신규 우레아계 또는 카바메이트계 p2x7 수용체 길항제 및 이를 유효성분으로 포함하는 주요 우울 장애의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151555A (en) * 1979-05-14 1980-11-26 Tanabe Seiyaku Co Ltd Proline derivatives and their production
US4402969A (en) * 1981-03-23 1983-09-06 Merck & Co., Inc. Antihypertensive proline derivatives
DE3134933A1 (de) * 1981-09-03 1983-03-31 Hoechst Ag, 6230 Frankfurt "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung"
JPS58170752A (ja) * 1982-03-30 1983-10-07 Kureha Chem Ind Co Ltd Ｎ−カルバモイルアミノ酸誘導体
DE4228455A1 (de) * 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US5264619B1 (en) * 1993-01-15 1996-05-14 Cosmos Pharm Corp Anti-androgenic cyclo and bicyclo alkenes
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5935989A (en) * 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters

Also Published As

Publication number Publication date
PL348671A1 (en) 2002-06-03
WO1999062879A1 (en) 1999-12-09
BG105014A (en) 2001-08-31
NO20006111D0 (no) 2000-12-01
ZA9811061B (en) 1999-12-03
US20020007075A1 (en) 2002-01-17
JP2002516903A (ja) 2002-06-11
CA2333960A1 (en) 1999-12-09
AU1620499A (en) 1999-12-20
EA200001246A1 (ru) 2001-08-27
BR9815881A (pt) 2002-07-23
KR20010052502A (ko) 2001-06-25
HUP0102847A2 (hu) 2001-12-28
WO1999062879A8 (en) 2000-05-04
NO20006111L (no) 2001-02-01
US20020042442A1 (en) 2002-04-11
SK18292000A3 (sk) 2001-07-10
CN1299346A (zh) 2001-06-13
EP1082301A1 (en) 2001-03-14

Similar Documents

Publication Publication Date Title
HUP0105027A3 (en) Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use
AU5420499A (en) Novel aryl sulphonamide amino acid esters and analogues
PL338633A1 (en) Derivatives of aryloxyarylsuphonylamino hydroxamic acid
PL337698A1 (en) Derivatives of 4-bromo- or iodo-phenylaminobenzhydroxamic acid and their application as mek inhibitors
PL331895A1 (en) Arylosulphonylamino derivatives of hydroxamic acid
HUP0100579A3 (en) Aminobutanoic acid derivatives and pharmaceuticals comprising them
HUP0102935A3 (en) N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres and pharmaceutical compositions containing them
DE59700915D1 (de) Stabilisierter Milchsäurementhylester
IL140039A0 (en) Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
ATE196764T1 (de) Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
PL335023A1 (en) Crystals of dicarboxylic acid
HUP0100597A3 (en) Hydroxamic and carboxylic acid derivatives
GB2298423B (en) Synthesis of carboxylic and hydroxamic acid derivatives
GB9507415D0 (en) Production and uses of caffeic acid and derivatives thereof
PL341221A1 (en) Derivatives of phenylaminoalkyl carboxylic acid and pharmacological compositions containing them
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
NO992751D0 (no) N-bundet urea og karbamater av heterocykliske tiolestere
PL341205A1 (en) Method of obtaining l-dihydroorotic acid and application thereof
HUP0103334A3 (en) Substituted cinnamic acids and cinnamic acid esters
PL332477A1 (en) Derivatives of hydroxamic acid
IL122919A (en) Preparation of 1-alkyl-pyrazole-5- carboxylic acid esters
ZA9811063B (en) Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds.
GB9911073D0 (en) Hydroxamic and carboxylic acid derivatives
DE968176T1 (de) Preparation of acylated alpha-amino carboxylic acid amides
DE69809692D1 (de) Herstellung von Carbonsäureestern